Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

UK MPs recalled to debate seizure of British Steel

(Sharecast News) - UK lawmakers will hold a rare emergency parliamentary session on Saturday to take control of British Steel and stop its Chinese owner closing the Scunthorpe plant in a move that could lead to nationalisation of the company. MPs will debate emergency laws at 1100 BST that will give Business Secretary Jonathan Reynolds authority to order the company - which is owned by China's Jingye - to buy the raw materials to keep two blast furnaces going at the plant and save 3,000 jobs. The taxpayer will take on purchase costs.

Jingye claims it is losing about £700,000 a day and maintains that the furnaces are unviable. Last year it rejected a £500m bailout plan put forward by the government.

Once stopped, the furnaces would be impossible to restart. Starmer on Friday said the future of British Steel "hangs in the balance".

A Downing Street spokesperson said: "Tomorrow, parliament will be recalled to debate the steel industry (special measures) bill. The bill provides the government with the power to direct steel companies in England, which we will use to protect the Scunthorpe site. It enables the UK government to preserve capability and ensure public safety. It also ensures all options remain viable for the future of the plant and the livelihoods it supports."

"We have been negotiating with British Steel's owners in good faith ever since coming to office. We have always been clear there is a bright future for steel in the UK. All options remain on the table."

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.